Showing results (151-160 of 218) with videos related to

Sort By:
Pageof 22
Blood Advances|April 25, 2022
Phase 1 study of CART-ddBCMA for the treatment of subjects with relapsed and refractory multiple myelomaMatthew J Frigault, Michael R Bishop, Jacalyn Rosenblatt, et al.
Blood Advances|August 3, 2021
Clonal hematopoiesis in patients receiving chimeric antigen receptor T-cell therapyPeter G Miller, Adam S Sperling, Elliott J Brea, et al.
Nature Communications|November 18, 2023
Anti-TACI single and dual-targeting CAR T cells overcome BCMA antigen loss in multiple myelomaRebecca C Larson, Michael C Kann, Charlotte Graham, et al.
Science Translational Medicine|June 5, 2024
Comparative analysis of Bcl-2 family protein overexpression in CAR T cells alone and in combination with BH3 mimeticsFelix Korell, Michael L Olson, Diego Salas-Benito, et al.
Cytometry. Part B, Clinical Cytometry|February 28, 2024
Optimization of a flow cytometry test for routine monitoring of B cell maturation antigen targeted CAR in peripheral bloodWon-Ho Lee, Charlotte E Graham, Hadley R Wiggin, et al.
Journal for Immunotherapy of Cancer|September 10, 2025
Tandem CAR-T cells targeting mesothelin and MUC16 overcome tumor heterogeneity by targeting one antigen at a timeDiego Salas-Benito, Filippo Birocchi, Sangwoo Park, et al.
Cell Chemical Biology|November 21, 2023
Genetic retargeting of E3 ligases to enhance CAR T cell therapyIsabel C Lane, Gabriele Kembuan, Jeannie Carreiro, et al.
Blood|November 21, 2024
CD70 CAR T cells secreting an anti-CD33/anti-CD3 dual-targeting antibody overcome antigen heterogeneity in AMLHarrison J Silva, Grace Martin, Filippo Birocchi, et al.
Nature Communications|May 9, 2019
Synthetic TRuC receptors engaging the complete T cell receptor for potent anti-tumor responsePatrick A Baeuerle, Jian Ding, Ekta Patel, et al.
Pageof 22